Driehaus Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-395,323
Closed -$51.4M 446
2025
Q4
$51.4M Sell
395,323
-14,707
-4% -$2.02M 0.35% 98
2025
Q3
$44.2M Buy
410,030
+106,575
+35% +$11.6M 0.32% 102
2025
Q2
$28M Sell
303,455
-151,501
-33% -$11.9M 0.22% 144
2025
Q1
$40.3M Buy
454,956
+130,038
+40% +$11.3M 0.39% 74
2024
Q4
$25M Sell
324,918
-147,865
-31% -$10.3M 0.21% 147
2024
Q3
$20.1M Buy
472,783
+39,148
+9% +$1.32M 0.17% 170
2024
Q2
$11.3M Buy
+433,635
New +$8.22M 0.11% 202
2022
Q2
Sell
-35,043
Closed -$3.55M 446
2022
Q1
$3.55M Hold
35,043
0.04% 313
2021
Q4
$5.16M Hold
35,043
0.05% 291
2021
Q3
$8.78M Sell
35,043
-11,582
-25% -$3.98M 0.1% 251
2021
Q2
$21.6M Buy
46,625
+2,566
+6% +$1.1M 0.29% 117
2021
Q1
$21.6M Buy
+44,059
New +$22.9M 0.32% 98

Other funds holding WGS

Driehaus Capital Management's WGS Position: Q1 2026 in Review

Driehaus Capital Management sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 395,323 shares — an estimated $51.4M sold.

Driehaus Capital Management first reported a position in WGS in Q1 2021 and held it in 12 quarters. The position peaked at $51.4M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Driehaus Capital Management reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 395,323 GeneDx Holdings shares in Q1 2026, an estimated $51.4M.
  • Driehaus Capital Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 12 quarters.
  • Driehaus Capital Management's GeneDx Holdings position peaked at $51.4M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.